TMCnet News
Research and Markets: Concise Analysis on the International Immunology Development StrategiesDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/d53z98/immunology) has announced the addition of the "Concise Analysis on the International Immunology Development Strategies" report to their offering. The immune system can be harnessed in one of several ways to tackle various diseases such as cancer, infection, auto-immune disease and inflammatory diseases. The complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly in relation to targeting the right genes, identifying the appropriate patient population and accessing internal tissues for testing. Oncology has been a primary area of focus for immunotherapeutics, largely due to the potential offered by this maret but also due to the critical role the immune system plays in the proliferation of cancer throughout the body. Auto-immune and inflammatory diseases are also attractive targets for immunotherapy, with several different approaches being investigated. This report was written to support executives within both the commercial and R&D sides of the biopharmaceutical industry. It provides key insights through the analysis of issues, trends, and the future outlook of immunological therapies to support executive decision making for both biotech and pharmaceuticals companies alike. Key Reasons to Purchase
Key Topics Covered: 1. Executive summary 2. Methodology 3. Immunotherapy Overview 4. Immunotherapeutic Development and Launch Strategies 5. Trends in the Development of Immunotherapeutics 6. The Immunotherapeutics Market Appendix For more information visit http://www.researchandmarkets.com/research/d53z98/immunology
|